• Search
July 14, 2020 11:37:00 | RK Online Desk

Russia plans to launch world’s first COVID-19 vaccine in mid-August

Russian scientists claimed on Monday that they hope to launch the world’s first coronavirus as soon as next month, as per report. On Sunday, Russia’s Sechenov University said that it had successfully completed clinical trials of a COVID-19 vaccine developed by the state-run Gamalei Institute of Epidemiology and Microbiology.

The head and chief researcher at Sechenov University Center for Clinical Research on Medications Elena Smolyarchuk told Russian news agency TASS that clinical trials of the vaccine on volunteers have been completed and study data showed the candidate’s effectiveness.

“The research has been completed and it proved that the vaccine is safe,” Smolyarchuk was quoted as saying by TASS of its trial.

The Gamalei center’s director Alexander Gintsburg told TASS that he hopes the vaccine will ‘enter civil circulation’ on August 12-14, adding that private companies may begin mass production by September, The Moscow Times reported.

Meanwhile, the World Health Organization’s protocols said that a vaccine has to go through three phases of studies before being approved for large-scale production. Also, WHO’s draft landscape of coronavirus vaccines lists the Russian candidate vaccine study as a phase 1 trial. Perhaps, till date, no vaccine has been approved for large-scale use without undergoing the third phase of testing, which is the largest in terms of the number of participants. A candidate vaccine usually undergoes industrial production if the last phase shows clear and definitive evidence of its safety and efficacy.

Archive
July 14, 2020 11:37:00 | RK Online Desk

Russia plans to launch world’s first COVID-19 vaccine in mid-August

              

Russian scientists claimed on Monday that they hope to launch the world’s first coronavirus as soon as next month, as per report. On Sunday, Russia’s Sechenov University said that it had successfully completed clinical trials of a COVID-19 vaccine developed by the state-run Gamalei Institute of Epidemiology and Microbiology.

The head and chief researcher at Sechenov University Center for Clinical Research on Medications Elena Smolyarchuk told Russian news agency TASS that clinical trials of the vaccine on volunteers have been completed and study data showed the candidate’s effectiveness.

“The research has been completed and it proved that the vaccine is safe,” Smolyarchuk was quoted as saying by TASS of its trial.

The Gamalei center’s director Alexander Gintsburg told TASS that he hopes the vaccine will ‘enter civil circulation’ on August 12-14, adding that private companies may begin mass production by September, The Moscow Times reported.

Meanwhile, the World Health Organization’s protocols said that a vaccine has to go through three phases of studies before being approved for large-scale production. Also, WHO’s draft landscape of coronavirus vaccines lists the Russian candidate vaccine study as a phase 1 trial. Perhaps, till date, no vaccine has been approved for large-scale use without undergoing the third phase of testing, which is the largest in terms of the number of participants. A candidate vaccine usually undergoes industrial production if the last phase shows clear and definitive evidence of its safety and efficacy.